DeepCurrents Investment Group »

Revance Therapeutics shares owned by DeepCurrents Investment Group

Quarter-by-quarter ownership of Revance Therapeutics shares owned by DeepCurrents Investment Group from 13F filings

Historical chart of DeepCurrents Investment Group investment in Revance Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Revance Therapeutics held by DeepCurrents Investment Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Revance Therapeutics by DeepCurrents Investment Group

Quarter filed Position value Share count Share price at filing
2024-12-31 $45k 15k 3.04
2024-09-30 $76k 15k 5.19

More positions owned by DeepCurrents Investment Group

At&t Put Option (T)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Bloom Energy Corp Note 3.000% 6/0 (Principal)
Sea Note 2.375%12/0 (Principal)
Nova Note 10/1 (Principal)
Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Stride Note 1.125% 9/0 (Principal)
Ionis Pharmaceuticals Note 4/0 (Principal)
Spotify Usa Note 3/1 (Principal)
Strategy Note 0.625% 9/1 (Principal)
Shift4 Pmts Note 12/1 (Principal)
Dexcom Note 0.250%11/1 (Principal)
Cloudflare Note 8/1 (Principal)
Novocure Note 11/0 (Principal)
Makemytrip Limited Mauritius Note 2/1 (Principal)

View all positions for DeepCurrents Investment Group